Elanco-Bayer animal-health deal open for comments
( April 23, 2020, 07:39 GMT | Official Statement) -- MLex Summary: Interested third parties are invited to provide feedback on plans by Elanco Animal Health to buy Bayer's veterinary business, the European Commission said in a note published in its official bulletin today.Notice follows. Prior notification of a concentration (Case M.9554 – Elanco Animal Health/Bayer Animal Health Division) (Text with EEA relevance) (2020/C 132/09) 1. On 14 April 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1). This notification concerns the following undertakings:...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.